Centrexion Therapeutics is transforming the treatment of chronic pain by advancing one of the largest, exclusively pain-focused clinical pipelines of novel, non-opioid therapies. It aims to bridge the safety and efficacy gaps in current approaches to chronic pain management.The pipeline represents the mission to tackle the problem of chronic pain head on by developing treatments that act at new or emerging pharmacological targets and delivering them in ways that best address the particular type of chronic pain. This includes a topical gel, a joint or deeper tissue injection, a spinal delivery, and three separate oral treatments.